CNTA(CNTA)
CNTA
ANALYST COVERAGE13 analysts
BUY
▲ +0.5%upside to target
L $38.00
Med $40.00consensus
H $42.00Key MetricsTTM
Market Cap$6.16B
Revenue TTM—
Net Income TTM—
Free Cash Flow-$209.17M
Gross Margin—
Operating Margin—
Net Margin—
Return on Equity-60.4%
Return on Assets—
Debt / Equity0.02
Current Ratio9.53
EPS TTM$-1.63
PRICE
Prev Close
39.75
Open
39.77
Day Range39.74 – 39.85
39.74
39.85
52W Range10.95 – 40.26
10.95
40.26
98% of range
VOLUME & SIZE
Avg Volume
2.6M
FUNDAMENTALS
P/E Ratio
-22.4x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.73
Low vol
TECHNICAL
RSI (14)
78
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
CNTA News
About
No description available.
Karen AndersonChief People Officer
Tia L. BushChief Technology & Quality Officer
Gregory WeinhoffChief Business Officer
Kimberly A. McCormickSenior Vice President of Regulatory Affairs & Medical Writing
Mario Alberto AccardiChief Executive Officer & Director
Stephen J. KanesHead of R&D and Chief Medical Officer
Iqbal J. HussainChief Legal Officer, Chief Compliance Officer & Company Secretary
John J. CrowleyChief Financial Officer
Raphael DeferiereChief Accounting Officer
Charlene StoudtSenior Vice President of Clinical Development Operations
Kristen K. SheppardSenior Vice President of Investor Relations & Corporate Communications